CN Patent

CN111163794A — 治疗狼疮性肾炎的改进方案

Assigned to Aurinia Pharmaceuticals Inc · Expires 2020-05-15 · 6y expired

What this patent protects

通过采用药效学给药方案，可在使不期望的副作用最小化的同时，最大程度地提高使用伏孢素治疗蛋白尿性肾脏疾病的方案的有效性。

USPTO Abstract

通过采用药效学给药方案，可在使不期望的副作用最小化的同时，最大程度地提高使用伏孢素治疗蛋白尿性肾脏疾病的方案的有效性。

Drugs covered by this patent

Patent Metadata

Patent number: CN111163794A
Jurisdiction: CN
Classification: —
Expires: 2020-05-15
Drug substance claim: No
Drug product claim: No
Assignee: Aurinia Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.